Further, an IL-34 neutralizing antibody could attenuate CSF1R/JAK3/STAT6 activation and down-regulate VEGF, MMP-2 and MMP-9, eventually leading to suppression of the development of endometriosis in vitro. This evidence concerns the gene MMP9 and endometriosis.